TickerFactsScreenerDevelopers

BridgeBio Pharma, Inc. (BBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$40.49M2018: -$136.64M2019: -$253.59M2020: -$399.71M2021: -$497.93M2022: -$419.49M2023: -$527.72M2024: -$520.73M2025: -$445.91M-$445.91M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$445.91M+14.4%
2024-$520.73M+1.3%
2023-$527.72M-25.8%
2022-$419.49M+15.8%
2021-$497.93M-24.6%
2020-$399.71M-57.6%
2019-$253.59M-85.6%
2018-$136.64M-237.5%
2017-$40.49M—